Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


BioScience News and Advocate Daily Highlights 9/2

Daily Highlights
1. No evidence bird flu passed from humans, WHO says
2. Leftover embryos could benefit research
3. Heart-healthy meat may be on the menu
4. Greenpeace challenges Monsanto patent
5. Balancing risks and benefits - Spiked online debate
6. Big pharma calls on small biotech firm


No evidence bird flu passed from humans, WHO says
Genetic evidence shows bird flu is not being passed from person to person in Vietnam, reassuring news that suggests the outbreaks that have killed 18 people have not become an epidemic, the World Heal...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6128

Leftover embryos could benefit research
It should be legal for leftover embryos from fertility treatments to be used for stem cell research, according to a keynote speaker at this week's New Zealand Bioethics Conference. Gareth Jones, p...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6126

Heart-healthy meat may be on the menu
Fish oils known to help prevent heart attacks can now be made by land animals for themselves, thanks to work by genetic engineers. The researchers inserted a gene from a nematode worm into mice wh...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6124

Greenpeace challenges Monsanto patent
Greenpeace is challenging patent rights to a wheat strain granted to Monsanto, the world's largest genetically modified (GM) seed company, on grounds of "biopiracy." The dispute continues the environm...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6123

Balancing risks and benefits - Spiked online debate
Continuing the Spiked online debate, Dr Gill Samuels of Pfizer writes about balancing the risks and benefits of research.In areas where new science and technologies are being employed, an e...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6120

Big pharma calls on small biotech firm
Three of the world's largest drug makers, Bristol-Myers Squibb, Abbott Laboratories and Eli Lilly, are turning to a tiny Silicon Valley company to help them develop drugs. Troy May writes in the S...
More...
http://www.BioSciNews.com/files/news-detail.asp?newsID=6118


From the BioScience News Team

BioScience Communications Limited
Editor: Christine Ross

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Onetai Station: Overseas Investment Office Puts Ceol & Muir On Notice

The Overseas Investment Office (OIO) has issued a formal warning to Ceol & Muir and its owners, Argentinian brothers Rafael and Federico Grozovsky, for failing to provide complete and accurate information when they applied to buy Onetai Station in 2013. More>>

ALSO:

Tomorrow, The UN: Feds President Takes Reins At World Farming Body

Federated Farmers president Dr William Rolleston has been appointed acting president of the World Farmers’ Organisation (WFO) at a meeting in Geneva overnight. More>>

ALSO:

I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>

ALSO:

Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>

Earlier:

Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>

ALSO:

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news